ArticleArteriosclerosis, thrombosis, and vascular biology2021
Anticytomegalovirus CD4
Open access · bronzeAbstract read
In one paragraph
Article in Arteriosclerosis, thrombosis, and vascular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 21 citations in OpenAlex.
- The CX3CL1-CX3CR1 axis in HIV-associated inflammation and cardiometabolic disease.American journal of physiology. Regulatory, integrative and comparative physiology · 2026Review
- Cytomegalovirus in HIV: A Modifiable Driver of Inflammation, Frailty, and Aging.Current HIV/AIDS reports · 2026Review
- Mapping CMV-related immune signatures in blood, aorta and perivascular mediastinal adipose tissue.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025Article
- Coronary Artery Disease in People Living with HIV May Reflect Their Sensitivity to Inflammation Associated with Cytomegalovirus.Pathogens (Basel, Switzerland) · 2025Article
- Understanding residual risk of cardiovascular disease in people with HIV.Current opinion in HIV and AIDS · 2025Review
- Mouse Models of HIV-Associated Atherosclerosis.International journal of molecular sciences · 2025Review
- Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus.Heart failure clinics · 2025Review
- Cytomegalovirus Antibodies and Coronary Artery Disease in People with HIV: A Cohort Study.Viruses · 2025Article
- Association of T-Cell Phenotypes With Peri-Coronary Inflammation in People With and Without HIV and Without Cardiovascular Disease.Circulation. Cardiovascular imaging · 2025Observational
- Cytokine and chemokine receptor profiles in adipose tissue vasculature unravel endothelial cell responses in HIV.Journal of cellular physiology · 2024Article
- Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV.International journal of molecular sciences · 2024Review
- CD3bioRxiv : the preprint server for biology · 2024Article
- Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease.Circulation research · 2024Review
- Exercise to Prevent Accelerated Vascular Aging in People Living With HIV.Circulation research · 2024Review
- CD4Frontiers in immunology · 2023Article
- Mean Coronary Cross-Sectional Area as a Measure of Arterial Remodeling Using Noncontrast CT Imaging in Persons With HIV.Journal of the American Heart Association · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 8 institutions in 3 countries.
Celestine N WanjallaDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Mona MashayekhiDivision of Diabetes, Endocrinology and Metabolism (M.M.), Vanderbilt University Medical Center, Nashville.
Samuel BailinDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Curtis L GabrielTennessee Center for AIDS Research (C.N.W., C.L.G., C.M.W., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Leslie M MeenderinkDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Tecla TemuDepartment of Global Health, University of Washington, Seattle (T.T.).
Daniella T FullerCVPath Institute, Gaithersburg, MD (D.T.F., L.G., K.K., R.V.).
Liang GuoCVPath Institute, Gaithersburg, MD (D.T.F., L.G., K.K., R.V.).
Kenji KawaiCVPath Institute, Gaithersburg, MD (D.T.F., L.G., K.K., R.V.).
Renu VirmaniCVPath Institute, Gaithersburg, MD (D.T.F., L.G., K.K., R.V.).
Cathy JenkinsDepartment of Biostatistics (C.J.), Vanderbilt University Medical Center, Nashville.
Chike O AbanaDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston (C.O.A.).
Christian M WarrenDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Rama GangulaDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Rita SmithDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Meena S MadhurDivision of Clinical Pharmacology (M.S.M., D.G.H.), Vanderbilt University Medical Center, Nashville.
Aloke V Finn
Alexander H GelbardDepartment of Otolaryngology (A.H.G., S.A.M.), Vanderbilt University Medical Center, Nashville.
Yan Ru SuDivision of Cardiovascular Medicine (Y.R.S., J.A.B.), Vanderbilt University Medical Center, Nashville.
Matthew J Tyska
Spyros A KalamsDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
David G HarrisonDivision of Clinical Pharmacology (M.S.M., D.G.H.), Vanderbilt University Medical Center, Nashville.
Simon A MallalDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Tarek S AbsiDepartment of Cardiac Surgery (T.S.A.), Vanderbilt University Medical Center, Nashville.
Joshua A BeckmanDivision of Cardiovascular Medicine (Y.R.S., J.A.B.), Vanderbilt University Medical Center, Nashville.
John R KoetheDivision of Infectious Diseases (C.N.W., S.B., L.M.M., C.M.W., R.G., R.S., S.A.K., S.A.M., J.R.K.), Vanderbilt University Medical Center, Nashville.
Vanderbilt University Medical Center · USCVPath Institute · USNorwegian Womens Public Health Association · NOSt. Matthew's University · KYThe University of Texas MD Anderson Cancer Center · USVanderbilt University · USVA Tennessee Valley Healthcare System · USWashington State Department of Health · US
Funding
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7MTennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John Koethe · 2015 to 2026
$27.5MInstitutional Career Development CoreKL2TR002245 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$9.3MVanderbilt Infection Pathogenesis and Epidemiology Research Training ProgramT32AI007474 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KALAMS, SPYROS A · 1995 to 2025
$6.9MMolecular basis of brush border assemblyR01DK095811 · NIDDK · VANDERBILT UNIVERSITY · PI MATTHEW J TYSKA · 2013 to 2026
$4.9MRole of I-BAR proteins in enterocyte differentiationR01DK111949 · NIDDK · VANDERBILT UNIVERSITY · PI MATTHEW J TYSKA · 2017 to 2026
$4.2MThe Impact of Diabetes on Revascularization in BEST-CLIR01HL131977 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ADAY, AARON W., BECKMAN, JOSHUA A · 2016 to 2020
$4.0MThe Role of Adipose-Resident T Cells in HIV-Associated Glucose IntoleranceR01DK112262 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KOETHE, JOHN · 2017 to 2021
$3.8MVanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)K12HL143956 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FREIBERG, MATTHEW S, KOETHE, JOHN · 2018 to 2022
$1.6MMyosin-2 function in the enterocyte terminal webR01DK125546 · NIDDK · VANDERBILT UNIVERSITY · PI TYSKA, MATTHEW J · 2021 to 2024
$1.4MInnate and Adaptive Immunity in HIV-associated Impaired Glucose Tolerance and DiabetesR56DK108352 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KOETHE, JOHN · 2015 to 2016
$979kThe Role of Obesity and Adipocytes in Immune Activation on Antiretroviral TherapyK23AI100700 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KOETHE, JOHN · 2012 to 2016
$600kBLRD VA IK2 BX004885NCATS NIH HHS KL2 TR002245NCRR NIH HHS UL1 RR024975NHLBI NIH HHS K12 HL143956NHLBI NIH HHS R01 HL131977NIAID NIH HHS K23 AI100700NIAID NIH HHS P30 AI110527NIAID NIH HHS T32 AI007474NIDDK NIH HHS R01 DK095811NIDDK NIH HHS R01 DK111949NIDDK NIH HHS R01 DK112262NIDDK NIH HHS R01 DK125546NIDDK NIH HHS R56 DK095811NIDDK NIH HHS R56 DK108352
Abstract
[Figure: see text].
Indexed as
CoinfectionAdultAsymptomatic DiseasesCarotid Artery DiseasesCase-Control StudiesCD4 Lymphocyte CountCD4-Positive T-LymphocytesCoronary Artery DiseaseCross-Sectional StudiesCytomegalovirusCytomegalovirus InfectionsEpitopesFemaleHeart Disease Risk FactorsHIV InfectionsHumansEpitopesglycoprotein B, SimplexvirusViral Envelope Proteinsatherosclerosiscardiovascular diseasescytomegalovirusHIVinflammation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.